evidence: Increasingly, European nations are adopting a more cautious approach to gender-affirming care among minors. In March, for example, the Norwegian Healthcare Investigation Board announced it would revise its current clinical recommendations with respect to "gender-affirming care" for minors. The updated guidelines would restrict the use of puberty blockers, cross-sex hormones and transition-related surgery to clinical research settings. Norway joins other European nations, such as Finland, Sweden and the U.K., in introducing limits on the provision of gender-affirming care to minors. [...] A common claim by Americans who oppose state restrictions on gender-affirming care for minors is that Sweden, Finland, the Netherlands and the U.K. have not done away with hormonal interventions, and therefore lawmakers who seek limits are presumably going against what European health authorities recommend. Additionally, voices in America’s "affirmative-medicine" movement point to Europe not having bans on gender-affirming care for minors. It’s true that Europeans aren’t banning such care, and so legislators in the U.S. who pursue bans are at odds with European recommendations. But this only tells part of an evolving and layered story.